1-3 of 3
Oumédaly Reman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II Study of Volasertib (BI 6727), an Intravenous Polo-Like Kinase (Plk) Inhibitor, in Patients with Acute Myeloid Leukemia (AML): Results From the Randomized Phase II Part for Volasertib in Combination with Low-Dose Cytarabine (LDAC) Versus LDAC Monotherapy in Patients with Previously Untreated AML Ineligible for Intensive Treatment

Johan Maertens, MD, PhD, Michael Lübbert, MD, Walter Fiedler, MD, Loic Fouillard, Alf Haaland, MD, Joseph M. Brandwein, MD, Stéphane Lepretre, MD, Oumédaly Reman, MD, Pascal Turlure, MD, Gesine Bug, Carsten Müller-Tidow, Alwin Krämer, MD, Florian Voss, PhD, Tillmann Taube, MD, Holger Fritsch, PhD, Hartmut Döhner, MD
Journal: Blood
Blood (2012) 120 (21): 411.
https://doi.org/10.1182/blood.V120.21.411.411
Published: 2012
Journal Articles

First Report On the H10 EORTC/GELA/IIL Randomized Intergroup Trial On Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients with Supra-Diaphragmatic Stage I/II Hodgkin's Lymphoma, for the Groupe d'Etude Des Lymphomes De l'Adulte (GELA), European Organisation for the Research and Treatment of Cancer (EORTC) Lymphoma Group and the Intergruppo Italiano Linfomi (IIL).

Marc PE André, MD, Oumédaly Reman, MD, Massimo Fédérico, MD, Pauline Brice, MD, Ercole Brusamolino, MD, Théodore Girinski, MD, Christophe Ferme, MD, Richard vander Maazen, MD, Monica Bellei, Catherine Sebban, MD, Franck Morschhauser, MD, PhD, Elly Lugtenburg, MD, Aspasia Stamatoullas, MD, Liliana Baila, MD, MSc, Catherine Fortpied, MSc, Michel Meignan, MD, John M. Raemaekers, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 97.
https://doi.org/10.1182/blood.V114.22.97.97
Published: 2009
Journal Articles

Safety and Efficacy of FLAMSA Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation From Related and Unrelated Donors in High Risk Acute Leukemia and MDS Patients: A Study From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry.

Giovanna Cannas, MD, Anne Huynh, Stéphane Morisset, MSc, Mohamad Sobh, Pharm.M, Nicole Raus, Frederic Garban, MD, Catherine Cordonnier, MD, Jacques-Olivier Bay, Jérôme Cornillon, Agnes Buzyn, Ibrahim Yakoub-Agha, MD, PhD, Catherine Faucher, Sylvie Francois, Pierre Bordigoni, Pr, Nathalie Fegueux, MD, Loic Fouillard, Marie Robin, MD, Eric Deconinck, Oumédaly Reman, MD, Nathalie Dhedin, Thierry De Revel, MD, PhD, Bruno Lioure, MD, Noel Milpied, MD, PhD, Mohamad Mohty, MD, PhD, Mauricette Michallet, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4335.
https://doi.org/10.1182/blood.V114.22.4335.4335
Published: 2009